Endogenous endophthalmitis in a rheumatoid patient on tumor necrosis factor alpha blocker

The development of anti-tumor necrosis factor (TNF) therapies is a milestone in the therapy of rheumatic diseases. It is of concern whether all potential undesired complications of therapy have been evaluated within clinical trials which have led to treatment approval. Specialists prescribing TNF bl...

Full description

Bibliographic Details
Main Authors: Agarwal Pankaj, Gallaghar Mick, Murphy Elizabeth, Virdi Meena
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2007-01-01
Series:Indian Journal of Ophthalmology
Subjects:
Online Access:http://www.ijo.in/article.asp?issn=0301-4738;year=2007;volume=55;issue=3;spage=230;epage=232;aulast=Agarwal